MARKET

SILO

SILO

Silo Pharma Inc
NASDAQ
3.208
-0.352
-9.88%
Opening 11:00 08/12 EDT
OPEN
2.800
PREV CLOSE
3.560
HIGH
3.399
LOW
2.750
VOLUME
325.89K
TURNOVER
--
52 WEEK HIGH
15.15
52 WEEK LOW
2.750
MARKET CAP
4.02M
P/E (TTM)
-0.4305
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 11h ago
Silo Receives European Patent For Preventive PTSD Therapy SPC-15
NASDAQ · 2d ago
Silo Pharma granted European patent covering PTSD therapy
TipRanks · 2d ago
Silo Pharma Says EPO Grants Patent Covering Preventative Approach Of Lead Candidate SPC-15, Intranasal, Nose-To-Brain Treatment Targeting PTSD And Stress-Induced Affective Disorders
Benzinga · 2d ago
Weekly Report: what happened at SILO last week (0803-0807)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 5d ago
Silo Pharma’s QwikAgents Engages AWS Premier Tier Services Partner Caylent To Design And Build AWS-Native QwikAgents Platform
Benzinga · 6d ago
Weekly Report: what happened at SILO last week (0727-0731)?
Weekly Report · 08/03 09:38
More
About SILO
Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. The Company’s therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes programs, such as for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Its lead product candidate, SPC-15, is designed as a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for treatment of stress-induced psychiatric disorders such as PTSD and anxiety disorders. SPC-14 targets glutamate receptor NDMAR and serotonin 5-HT4 to address cognitive and neuropsychiatric symptoms in Alzheimer’s disease. SPU-16 is a candidate targeting central nervous system (CNS) disorders, with an initial indication for multiple sclerosis.

Webull offers Silo Pharma Inc stock information, including NASDAQ: SILO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SILO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SILO stock methods without spending real money on the virtual paper trading platform.